Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation.

Journal of cancer research and clinical oncology - 1 May 2005

Scholl Sebastian, Loncarevic Ivan F, Krause Claudia, Clement Joachim H, Höffken Klaus, Sayer Herbert G

Abstract excerpt

PURPOSE: Activating Flt3 mutations are observed in about 30% of patients with acute myeloid leukaemia (AML) and individual Flt3 mutations are applicable for minimal residual disease (MRD) analyses. METHODS: We investigated the MRD status in four AML patients carrying different Flt3 mutations (three patients with Flt3 length mutations of the juxtamembrane domain, one patient carrying a mutation of the Flt3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Primers
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm, Residual

Share to Polymerase Chain Reaction

Share to Salvage Therapy

Share to Stem Cell Transplantation

Share to Transplantation, Homologous

Source

Identifiers

PMID: 15645287
DOI: 10.1007/s00432-004-0660-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation.PMID 15645287Read ↗

Significance of Measurable Residual Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaSemantic proximity Read ↗

Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia.Semantic proximity Read ↗

Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.Semantic proximity Read ↗

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.Semantic proximity Read ↗

Minimal residual disease in acute myelogenous leukemia.Semantic proximity Read ↗

Minimal residual disease and stem cell transplantation outcomes.Semantic proximity Read ↗

Monitoring of minimal residual disease in acute myeloid leukemia.Semantic proximity Read ↗

Molecular methods used for detection of minimal residual disease following hematopoietic stem cell transplantation in myeloid disorders.Semantic proximity Read ↗

Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation.Semantic proximity Read ↗

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.Semantic proximity Read ↗

Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia.Semantic proximity Read ↗

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.